On the Frontlines of Psoriasis

Genetic insights are reshaping how we understand the development and comorbidities of psoriasis, as well as treatment response in patients. Hear Dr. Audrey Bui discuss…

Inflammatory skin diseases like psoriasis don’t just affe…

Home-based narrowband UVB phototherapy may offer a more accessible and e…

Psoriasis affects nearly eight million adults in the US, but its impact isn’t felt equally; significant disparities in diagnosis exist across race, ethnicity, an…

Psoriasis is more than just a skin condition—it can significantly impact a patient’s relationships, daily functioning, and overall quality of life. Tune in to hea…

From novel oral therapies to advancements in biologic injections, the treatment landscape for psoriasis is rapidly evolving. Here to share his insights on ho…

While systemic therapies like deucravacitinib have previously only been recommended for patients with moderate-to-severe plague psoriasis, it may be worth qu…

Researchers speculate that the Mediterranean Diet may have benefits for psoriasis patients because of its anti-…

A recent retrospective study using the Alberta Health Services Data Repository of Reporting found that patients with psoriasis had a significantly lower lifespan…

As the only FDA-designated selective TYK2 inhibitor, deucravacitinib has emerged as a potential therapeutic option for scalp psoriasis. And after analyzing i…

Managing psoriasis, psoriatic arthritis, and axial spondyloarthritis with ixekizumab may cause adverse effects in patients. That’s why a recent research rev…

A recent study led by Dr. Philip J. Mease examined the factors contributing to biologic therapy switching among patients with psoriasis and psoriatic arthritis. U…

Oftentimes patients with skin of color are diagnosed with psoriasis at a later stage than Caucasian patients. There are also di…

According to a recent study, patients with skin of color waited three times longer to be formally diagnosed with pso…

According to recent studies, only about 50 percent of psoriasis patients are adherent to topical medications by the end of…

There are a few key points that dermatologists need to keep at the forefront of conversations to help bridge education …

A recent study was conducted looking at initial therapies for newly diagnosed psoriasis patients by race. Prior studies have shown differences by race in terms of em…

Getting the proper treatment for patients with psoriasis and psoriatic arthritis can be life-changing. So how can clinicians …

Tune in as Dr. Mark Lebwohl, professor and chairman of the Department of Dermatology at The Mount Sinai School of Medicine, shares a c…

Here to give us insight into the strategies he uses to personalize therapeutic approaches for his patients with severe psoriasis is Dr…